2025 annual financial data
TScan Therapeutics 2025 Financial results
Direct answer
Revenue was 10.33M USD.
Operating income was -135.81M USD and net income was -129.77M USD.
Operating cash flow was -135.32M USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10.33M USD
- Operating income
- -135.81M USD
- Net income
- -129.77M USD
- Operating cash flow
- -135.32M USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TScan Therapeutics financial years